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Purpose: To evaluate factors behind the delay in diagnosis and treatment among Egyptian 
patients who present with complicated diabetic retinopathy.
Methods: Observational cross-sectional study of diabetic patients with advanced diabetic 
retinopathy. Patients were asked to answer a questionnaire to assess the impact of several 
sociodemographic factors.
Results: A total of 397 patients agreed to take the questionnaire. Diabetic vitreous hemorrhage 
was the most common ocular complication and was found in 359 patients (90.4%). A total of 
158 (39.8%) patients knew that diabetes mellitus can be sight threatening, while 240 (60.2%) 
were not aware until they developed sight threatening complication. A total of 179 patients 
(45.1%) had early retirement because of visual loss related to diabetes mellitus. Multivariate 
logistic regression has shown that education, internist, contact with other patients, and media 
were respectively significant in predicting the awareness of patients about the sight-threatening 
effect of diabetic retinopathy.
Conclusion: Patient education regarding diabetes and diabetic eye disease is essential for early 
detection and compliance with treatment. Illiteracy has a significant impact on development 
of sight-threatening diabetic complications. The internist is the first line of prophylaxis. Media 
has to participate more in patient education.
Keywords: blindness, education, laser photocoagulation, macular edema, vitreous 
hemorrhage
Introduction
Diabetes mellitus is an increasing health problem that currently affects more than 
150 million people worldwide and is expected to affect more than 200 million people 
by the year 2025.1 Diabetes mellitus is a chronic metabolic multisystem disease. 
Complications from diabetes can be classified as microvascular or macrovascular. 
Microvascular complications include system damage as diabetic peripheral neuropa-
thy, renal nephropathy, and diabetic retinopathy. Macrovascular complications include 
cardiovascular disease and stroke, and peripheral vascular disease, which may lead to 
diabetic foot, gangrene, and amputation.2
Herman et al3 found that diabetic retinopathy accounted for about 42% of diabetic 
patients in Egypt; however, the study done by Macky et al4 found the incidence to be 
20.5%. This improvement could be attributed to early detection of diabetic patients, 
with better medical care.3,4 The duration of diabetes remains the most significant pre-
dictor of visual impairment among people with type II diabetes.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Visual loss in diabetic patients is often a late symptom 
of advanced diabetic retinopathy, with serious undesirable 
consequences affecting the health and vision-related quality 
of life.5 The progression of diabetic retinopathy can have a 
deleterious effect on patients, both physically and emotion-
ally. Advanced diabetic eye disease can have a   significant 
economic burden on the patient, family members, society, 
and the health care system.6
According to the recommendations of the American 
Academy of Ophthalmology, the first fundus examination in 
patients with type I diabetes mellitus should be performed 
5 years after diagnosis because retinopathy rarely develops 
before this period. However, patients with type II diabetes 
mellitus should be examined immediately when they are 
diagnosed, because the duration of diabetes is uncertain 
and some degree of diabetic retinopathy may be present.7–9
Several multicenter studies have shown that if laser 
photocoagulation is initiated at the proper time for treat-
ment of diabetic retinopathy, the probability of blindness is 
considerably reduced. Hence proper management of diabetic 
eye disease requires collaboration between an internist and 
an ophthalmologist.10–13 Furthermore, patient education 
regarding diabetes and diabetic eye disease is essential for 
compliance with treatment.
The primary objective of this study is to highlight socio-
demographic factors responsible for blindness caused by 
diabetic retinopathy among the Egyptian population.
Materials and methods
This study was conducted among a sequential sample of 397 
diabetic patients with preventable or treatable retinal com-
plications. The study included patients presented to govern-
mental hospitals of Kasr El eini (Cairo University Hospital), 
Beni-Suef University Hospital, insurance clinics, Agooza and 
Mabarra Ministry of Health hospitals, and private clinics 
where the authors work. These patients represented samples 
from almost all health sectors in Egypt: national health 
insurance, ministry of health, university teaching hospitals, 
and the private sector. The study was conducted between 
February 2008 and March 2010.
Inclusion criteria included patients with diabetic vitre-
ous hemorrhage, tractional retinal detachment involving or 
threatening the macula, rubeosis irides, macular edema with 
foveal hard exudates, and cystoid or ischemic maculopathy. 
Exclusion criteria included all diabetic patients without the 
abovementioned complications and patients with peripheral 
stationary tractional retinal detachment.
During examination of diabetic patients, those who are 
legally blind secondary to advanced diabetic retinopathy 
were asked to answer a questionnaire (Table 1). The data 
included age, sex, residence, educational level, duration of 
diabetes, duration of diabetes adjustment, type of therapy, 
family   history of diabetes, consanguinity, smoking, asso-
ciated   systemic disease (eg, hypertension, nephropathy, 
  neuropathy, cerebrovascular, myocardial infarction), associ-
ated cataract, and glaucoma. Several questions were used to 
assess the patient education regarding diabetic eye disease 
and its impact on their occupational status, laser treatment, 
and cost of treatment of diabetic retinopathy.
Data analysis
Data were statistically described in terms of mean ± standard 
deviation (SD), frequencies (number of cases) and relative 
Table 1 The questionnaire
  1. hospital or clinic
  2. Age
  3. gender
  4. residence: urban, rural, or suburban
  5. educational level
  6. Onset of diabetes
  7. Treatment: tablets or insulin
  8. Controlled or not, and duration of control
  9. Family history of diabetes
10. Consanguinity
11. Associated conditions:
    a. systemic:
    i. hypertension
    ii. renal
    iii. smoking even if passive or ex-smoker
    iv. heart
    v. neuropathy? Foot or hand tingling and numbness
    vi. Cerebral infarction
    b. Ocular:
    i. glaucoma
    ii. Cataract
12. Do you follow up with a physician?
13.   Prior to visual impairment, did your physician tell you about periodic 
ocular check up?
14.   Why did you consult an ophthalmologist? regular follow up or when 
vision dropped
15.   Before you met ophthalmologist, did you know that diabetes could 
lead to blindness?
16.   source of information about diabetic eye disease? internist, 
ophthalmologist, patients, media, or readings
17. history of laser treatment?
18. Costs of treating diabetic retinopathy
19. impact of eye condition on the patient functioning and career
20.   Ocular condition: diabetic vitreous hemorrhage, tractional retinal 
detachment involving or threatening the macula, rubeosis irides, macular 
edema with foveal hard exudates, cystoid or ischemic maculopathyClinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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frequencies (percentages) when appropriate. Multivariate 
logistic regression analysis was done to test for the preferen-
tial effect of the independent variables of age, sex, residence, 
education, source of information about diabetic retinopathy, 
and the awareness of patients about the sight-threatening 
effect of diabetes mellitus. A probability value (P-value) 
less than 0.05 was   considered statistically significant. All 
statistical calculations were done using computer programs 
Microsoft Excel 2003 (Microsoft Corporation, NY) and SPSS 
(SPSS Inc, Chicago, IL).
Results
The data were collected from these patients. As shown in 
Table 2, the mean age was 56 years (SD ± 8.56). The num-
ber of  males was 155 (39%) and females was 242 (61%). 
A total of 123 (31%) reported they smoke, whereas 274 
(69%) did not.
There were 196 patients (49.4%) living in urban areas, 
144 (36.3%) in rural and 57 (14.4%) living in suburban 
areas. The mean duration of diabetes mellitus was 16.1 years 
(SD 6.78). Family history of diabetes mellitus was positive 
among 320 (80.6%), whereas 77 patients (19.4%) had no 
family   history of diabetes mellitus. Consanguinity was posi-
tive among 98 patients (24.7%).
The patients’ levels of education were also recorded. 
Out of the 397 patients, 140 (35.3%) were found illiterate, 
59 (14.9%) were able to read and write, 161 (40.6%) had 
some degree of education ranging from primary to high 
school diploma, 35 (8.8%) had a graduate university degree, 
and only 2 (0.5%) had postgraduate studies.
Diabetic peripheral neuropathy was the most common 
associated systemic disorder, with tingling and parathesia 
symptoms recorded in 350 (88.2%) patients. Hypertension 
ranked second, with 237 (59.7%) patients. Cardiovascular 
disease such as myocardial infarction was noted in 64 (16.1%) 
patients. Nephropathy was reported among 23 (5.8%) 
patients, and 20 (5%) patients had a prior cerebrovascular 
accident.
The most common cause of blindness was diabetic vitre-
ous hemorrhage affecting 359 patients (90.4%). Other causes 
of   blindness were tractional detachment (165 patients, 41.6%), 
cystoid macular edema or foveal hard exudates (114 patients, 
28.7%), end stage diabetic retinopathy (37 patients, 9.32%), 
and central retinal vein occlusion (16 patients, 4%).
A total of 164 (41.3%) patients had associated cataract. 
Glaucoma was reported in 23 patients (5.8%): 13 (3.3%) 
patients were noted to have primary open angle glaucoma, 
while 10 (2.5%) patients had neovascular glaucoma.
A total of 349 (87.9%) patients reported regular follow 
up with an internist, whereas 48 (12.1%) did not.
In our structured interview, we assessed patient   education, 
source of information about diabetic retinopathy, and the 
effectiveness of the doctor–patient relationship.
When questioned about diabetic retinopathy as a cause 
of blindness, only 158 (39.8%) patients knew that diabetes 
  mellitus can be sight threatening, while 239 (60.2%) were not 
aware until they developed sight-threatening   complications. 
Only 118 (29.7%) were informed by the internist about 
the necessity of dilated fundus examination. Forty-two 
patients (10.6%) reported that they follow up regularly with 
an ophthalmologist, whereas 355 (89.4%) reported that 
they have been to ophthalmologist only because of visual 
deterioration.
Regarding patient education and source of information 
about diabetic retinopathy, 139 (35%) chose their internist, 
391 (98.5%) chose their ophthalmologist, 59 (14.9%) referred 
to other patients, 34 (8.6%) chose media, while 14 (3.5%) 
acquired their knowledge on diabetic retinopathy through 
reading printed articles.
Multivariate logistic regression in Table 3 showed that 
age, sex, residence, patient knowledge acquired through 
Table 2 sociodemographic and clinical data
Sociodemographic data Mean ± SD Patient number (%)
Age, years 56 (8.56)
sex
  Male 155 (39%)
  Female 242 (61%)
residence
  Urban 196 (49.4%)
  rural 144 (36.3%)
  suburban 57 (14.4%)
Duration of diabetes  
mellitus in years
16.1 (6.78)
Family history of  
diabetes mellitus
320 (80.6%)
Consanguinity 98 (24.7%)
Associated systemic disease
  Peripheral neuropathy 350 (88.2%)
  hypertension 237 (59.7%)
  Cardiovascular disease 64 (16.1%)
  nephropathy 23 (5.8%)
    Cerebrovascular  
disease (stroke)
20 (5%)
Associated ocular disease
  Cataract 164 (41.3%)
  POAg 13 (3.3%)
  neovascular glaucoma 10 (2.5%)
Abbreviations: POAg, primary open angle glaucoma; sD, standard deviation.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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ophthalmologist, and reading printed articles were found 
insignificant, while education level (odds ratio [OR] 1.47, 
confidence interval [CI] 1.092–1.99, P = 0.01), internist 
(OR 156.1, CI 63.31–384.63, P , 0.001), contact with 
other patients (OR 8.51; CI 2.99–24.23; P , 0.001), and 
media (OR 29.96; CI 5.57–161.26; P , 0.001) had a sig-
nificant impact on awareness of patients about diabetic 
retinopathy.
A total of 130 patients (32.7%) received laser treatment 
for diabetic retinopathy at the time of the survey.
Regarding the impact of diabetic eye disease on work, 179 
(45.1%) took early retirement because of visual loss related 
to diabetes mellitus.
A total of 291 (73.3%) patients partially paid for their 
diabetic retinopathy treatment. The cost varied from 20 
to 8000 Egyptian pounds with a mean of 630.5 Egyptian 
pounds. The government supported 314 (79.1%) patients. 
The cost varied from 300 to 8200 Egyptian pounds with 
a mean of 2523.41 Egyptian pounds paid by Ministry 
of Health and National Health Insurance. The total eco-
nomic burden for treating diabetic eye disease in these 
patients was 975,840 Egyptian pounds: the government 
paid 792,350 (81.2%), while patients paid 183,490   
(18.8%).
Discussion
The Wisconsin Epidemiological Study of Diabetic 
  Retinopathy (WESDR) concluded that 3.6% of those diag-
nosed with type I and 1.6% of those diagnosed with type II 
diabetes mellitus were legally considered blind. For type I 
diabetes mellitus, blindness was mostly (86%) due to diabetic 
  retinopathy. For type II, blindness was related to retinopathy 
in 33% of the cases.14
The annual incidence of retinopathy requiring ophthal-
mological follow up or treatment has been reported to aver-
age 1.5% after 1 year. Between 6% and 9% of patients with 
proliferative retinopathy or severe nonproliferative disease 
would become blind each year.15
In our study, living in urban areas was not an advantage; as 
196 (49.4%) of the patients included in this study developed 
advanced diabetic eye disease.
Our results show that patient awareness about diabetic 
retinopathy was low, since only 158 (39.8%) knew about 
the possible deleterious effect of diabetes on eyesight. 
This may be related to low patient education, as 140 
(35.2%) were illiterate. Illiteracy may contribute to non-
compliance and inefficient doctor–patient education. Low 
income may discourage patients from seeking medical   
advice.
However, the result for patient awareness in the present 
study is higher than in other Egyptian and Indian stud-
ies which demonstrated that 14.7% and 18% of patients 
respectively were aware of the hazards of diabetes mellitus 
for the eyes.4,16 The difference may be attributed to better 
distribution of the patient sample through all socioeconomic 
classes of the Egyptian population and not only the low, 
illiterate one.
Effective methods to deliver patient education and teach 
self-management skills that result in longer-term improve-
ments to health are needed. All primary care organizations, 
as suggested by the Diabetes National Service Framework 
and the National Institute for Clinical Excellence, must offer 
structured educational programs to people with diabetes in 
order to improve glycemic control, reduce requirement for 
diabetes medication, improve early detection of diabetic 
complications, and treatment satisfaction.17–22
Multivariate logistic regression showed the impor-
tance of edication in predicting patients’ awareness about 
diabetic retinopathy (Odds ratio, 1.47, CI 1.092–1.99, 
P = 0.01). With regard to the source of information on 
diabetic retinopathy, our result shows that the sources were 
multiple and patients’ level of knowledge varied. Almost 
one-third of the patients acquired their knowledge through 
their internist, while most (391, 98.5%) chose their oph-
thalmologist after their visual loss. Multivariate logistic 
regression showed the role of the internist to be of utmost 
importance in predicting the awareness of patients about 
Table 3 The preferential effect of independent variables (age, sex, 
residence, education, role of internist, ophthalmologist, patient, 
and media in predicting the awareness of patients about the sight-
threatening effect of diabetes mellitus
Independent  
variable
Odds  
ratio
95% CI for  
odds ratio
P-value
Lower Upper
Age 1.013 0.965 1.064 0.603
sex 2.051 0.790 5.326 0.140
residence 1.131 0.628 2.038 0.682
education level 1.473 1.092 1.987 0.011
internist 156.058 63.318 384.632 0.000
Ophthalmologist 0.573 0.021 15.947 0.743
Patient 8.508 2.988 24.226 0.000
Media 29.962 5.567 161.257 0.000
reading 0.69 0.001 11.9 0.998
Abbreviation: CI, confidence interval.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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diabetic retinopathy with OR 156.1, CI 63.31–384.63, 
P , 0.001. Patients present late to the ophthalmologist, and 
the role of the internist in the prophylaxis, patient education, 
and early detection of diabetic retinopathy is crucial.
Although 59 (14.9%) patients referred to other patients 
and 34 (8.6%) chose media as a source of information 
about diabetic eye disease, both sources were found to be 
  statistically significant in promoting patients’ awareness 
about the sight-threatening effect of diabetes mellitus (other 
patients OR 8.5, CI 2.99–24.23, P , 0.001 and media 
OR 29.96; CI 5.57–161.26, P , 0.001, respectively).
Laser photocoagulation represents the mainstay of pro-
phylaxis against complications of diabetic retinopathy.11 In 
our study, only 32.7% of patients received laser treatment at 
the time of the survey.
This study showed that the Egyptian government car-
ried most of the direct costs of treating diabetic retinopathy. 
The government expenditure constituted 81.2%, while the 
patient’s economic burden was only 18.8%. The indirect cost 
could not be calculated. The main bulk of the indirect cost is 
lost productivity due to temporary work disability, absentee-
ism, early retirement, rehabilitation, and medication fee.22 
In this study, 45.1% had early retirement because of visual 
loss related to diabetes mellitus.
The strength of our study lies in the relatively large 
sample size of patients and the structured interview, which 
included much sociodemographic data besides the clinical 
examination. This descriptive study has included data from 
several referral centers representing the four main health 
organizations in Egypt.
The following limitations have to be realized: firstly, the 
self-reported nature of the questionnaire is subject to infor-
mant bias; and secondly, the selection bias, which is due to 
exclusion of diabetic patients with normal fundus.
In conclusion, this descriptive study found that illit-
eracy contributes to noncompliance and late presenta-
tion. The role of the internist and media in improving the 
awareness of patients about diabetic retinopathy is of utmost 
importance.
A continuous medical education program with implemen-
tation of evidence-based practices and screening programs 
for early detection of diabetic retinopathy are essential to 
improve the standard of care.
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